NTRB
Nutriband specializes in innovative transdermal drug delivery and abuse-deterrent platforms aimed at reducing misuse and enhancing patient care. The company focuses on opioid safety, with technologies like AVERSA developed through its clinical subsidiary 4P Therapeutics to revolutionize how certain medications are delivered. Headquartered in Orlando, Florida, Nutriband operates through its subsidiaries to develop, manufacture, and advance transdermal and other drug delivery solutions. The business emphasizes improving safety, efficacy, and patient outcomes in the pharmaceutical space, with an
No recent news for this company.
No recent deals for this company.